Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 G banding in cytogenetic study of hemoblastoses.

Literature DB >> 1056893

G banding in cytogenetic study of hemoblastoses.

Abstract

G banding was used in the study of the karyotype of malignant cells in 10 patients: 5 with CML (3 in blastic crisis), 3 with AL and 2 with lymphosarcomas. In all cases of CML 22q-- (Ph1-chromosome) and 9q+ were present in leukemic cells. An i(17q) was observed in the karyotype of 2 out of 3 patients in blastic crisis of CML. In AL and lymphosarocmas small chromosome rearrangements were revealed and the origin of marker chromosomes could be established by the aid of G banding.

Entities: Chemical Disease Species

Mesh：

Year: 1975 PMID： 1056893 DOI： 10.1007/bf00285385

Source DB: PubMed Journal: Humangenetik ISSN： 0018-7348

12 in total

1. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors: J D Rowley
Journal: Nature Date: 1973-06-01 Impact factor: 49.962

2. Identification of isochromosome 17 in myeloid leukaemia.

Authors: D S Lobb; B R Reeves; S D Lawler
Journal: Lancet Date: 1972-04-15 Impact factor: 79.321

3. Marker band in one chromosome 14 from Burkitt lymphomas.

Authors: G Manolov; Y Manolova
Journal: Nature Date: 1972-05-05 Impact factor: 49.962

4. Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence.

Authors: M L O'Riordan; J A Robinson; K E Buckton; H J Evans
Journal: Nature Date: 1971-03-19 Impact factor: 49.962

5. Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant.

Authors: M A Lutzner; I Emerit; R Durepaire; G Flandrin; C Grupper; M Prunieras
Journal: J Natl Cancer Inst Date: 1973-05 Impact factor: 13.506

4. Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.

Authors: E W Fleischman; E L Prigogina; M A Volkova; M A Frenkel; N A Zakhartchenko; L N Konstantinova; G P Puchkova; S A Balakirev
Journal: Hum Genet Date: 1981 Impact factor: 4.132

5. Certain patterns of karyotype evolution in chronic myelogeneous leukaemia. Chromosome abnormalities in CML.

Authors: E L Prigogina; E W Fleischman
Journal: Humangenetik Date: 1975-11-06

5 in total

G banding in cytogenetic study of hemoblastoses.

1. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

2. Identification of isochromosome 17 in myeloid leukaemia.

3. Marker band in one chromosome 14 from Burkitt lymphomas.

4. Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence.

5. Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant.

6. Cytogenetics of malignant lymphomas. Studies utilising a Giemsa-banding technique.

7. Identity of the abnormal F-group chromosome associated with polycythaemia vera.

8. [Eleven observations on a precise model of karyotype changes in the course of chronic myeloid leukemia].

9. Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis.

10. Fluorescent marker Chromosomes in malignant lymphomas.

1. Marker chromosome 14q+ in two non-Burkitt lymphomas.

2. Karyotype peculiarities of malignant lymphomas.

3. Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia.

4. Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.

5. Certain patterns of karyotype evolution in chronic myelogeneous leukaemia. Chromosome abnormalities in CML.